Symposium 14: Alternative Sampling Strategies to Evaluate in utero Drug Exposure

Wednesday September 16, 1400-1500 (UTC)

Testing for Neonatal Drug Exposure in Umbilical Cord
Kamisha Johnson-Davis, University of Utah / ARUP Laboratories, USA

Learning Objectives: At the end of this session participants will be able to:
- Discuss the importance of drug testing to assess in utero drug exposure.
- Discuss the strengths and weaknesses of umbilical cord tissue for drug testing.
- Describe the pros/cons of drug testing via ELISA screen vs mass spectrometry.

Drugs and Placenta Exposure: New Methods Using Placenta Models, Meconium and Innovative Biomarkers
B.C.P. Koch, Erasmus MC, Netherlands

Learning Objectives: At the end of this session participants will be able to:
- Explain placenta transfer.
- Discuss meconium and drugs analysis.
- Discuss new biomarkers and drug abuse.

Question Title

* 1. This session overall

	Disagree	Neutral	Agree	Strongly Agree
Sufficient time was allowed for audience participation/active learning	Sufficient time was allowed for audience participation/active learning Disagree	Sufficient time was allowed for audience participation/active learning Neutral	Sufficient time was allowed for audience participation/active learning Agree	Sufficient time was allowed for audience participation/active learning Strongly Agree
The session was free from commercial bias	The session was free from commercial bias Disagree	The session was free from commercial bias Neutral	The session was free from commercial bias Agree	The session was free from commercial bias Strongly Agree

Comments:

Question Title

* 2. Overall, I would rate this symposium as:

Fair

Good

Excellent

Comments

Question Title

* 3. Speaker: Kamisha Johnson-Davis

	Fair	Good	Very Good	Outstanding
Knowledgeable, organized and effective	Knowledgeable, organized and effective Fair	Knowledgeable, organized and effective Good	Knowledgeable, organized and effective Very Good	Knowledgeable, organized and effective Outstanding
Educational content/Relevance to practice	Educational content/Relevance to practice Fair	Educational content/Relevance to practice Good	Educational content/Relevance to practice Very Good	Educational content/Relevance to practice Outstanding
Balanced and unbiased	Balanced and unbiased Fair	Balanced and unbiased Good	Balanced and unbiased Very Good	Balanced and unbiased Outstanding

Comments

Question Title

* 4. Speaker: B.C.P. Koch

	Fair	Good	Very Good	Outstanding
Knowledgeable, organized and effective	Knowledgeable, organized and effective Fair	Knowledgeable, organized and effective Good	Knowledgeable, organized and effective Very Good	Knowledgeable, organized and effective Outstanding
Educational content/Relevance to practice	Educational content/Relevance to practice Fair	Educational content/Relevance to practice Good	Educational content/Relevance to practice Very Good	Educational content/Relevance to practice Outstanding
Balanced and unbiased	Balanced and unbiased Fair	Balanced and unbiased Good	Balanced and unbiased Very Good	Balanced and unbiased Outstanding

Comments

Question Title

* 5. As a result of attending this session, I am planning to:

a) Discuss the session with my colleagues.

b) Pursue additional learning activities.

c) Create/revise protocols, policies, and/or procedures.

d) Not change my practice.

Symposium 14: Alternative Sampling Strategies to Evaluate in utero Drug Exposure

Wednesday September 16, 1400-1500 (UTC)

Question Title

* 1. This session overall

Question Title

* 2. Overall, I would rate this symposium as:

Question Title

* 3. Speaker: Kamisha Johnson-Davis

Question Title

* 4. Speaker: B.C.P. Koch

Question Title

* 5. As a result of attending this session, I am planning to:

Question Title

* 6. Please explain any changes you plan to make or personal learning projects you will pursue as a result of this session:

Question Title

* 7. What topics would you like to be addressed at future conferences to keep you up to date in your profession?